Pharmaceutical Sciences News

BUFFALO, N.Y. -- Joseph Balthasar, PhD, professor of pharmaceutical sciences, has been selected to receive the 2020 University at Buffalo (UB) Exceptional Scholar Sustained Achievement Award.

Javier G. Blanco, Clin. Biochem., PhD, professor, pharmaceutical sciences, has accepted an invitation to serve in the Cardiac Contractility, Hypertrophy, and Failure Study Section (CCHF), Center for Scientific Review, for the National Institutes of Health (NIH).

BUFFALO, N.Y. — A new study funded by the Multiple Sclerosis Research Program of the U.S. Army Medical Research and Development Command will explore the role of metabolic pathways on the progression of neurodegeneration in multiple sclerosis (MS).

Donald Mager, BS ’91, PharmD ’00 & PhD ’02, professor and vice-chair, pharmaceutical sciences, has been elected president of the American College of Clinical Pharmacology (ACCP) for 2020-2022.

Joseph Balthasar, BS '91 & PhD '96, professor, pharmaceutical sciences, has received a new $1.8 million R01 grant from the National Cancer Institute (NCI) to develop strategies to improve the safety and efficacy of anti-cancer antibodies and antibody-drug conjugates.